Universal immunization of newborns against respiratory syncytial virus (RSV) could prevent 61% of RSV-related hospitalizations in infants during their first two months of life, according to a model cited by the European Centre for Disease Prevention and Control (ECDC), as Europe prepares for the cold season.
Key Findings from ECDC Models
Models assessed by the ECDC indicate that administering long-acting monoclonal antibodies to 90% of newborns at birth could reduce RSV-related hospitalizations by 61% in the first two months of life. This approach, highlighted by Bruno Ciancio, ECDC Head of Unit, offers a tool to do just that
amid rising concerns about respiratory infections during colder months.
Protecting infants from RSV in the first months of their life is particularly important, and we have a tool to do just that. Universal immunization of newborns against RSV can reduce the risk of hospitalization due to respiratory infections in young children by more than half.
Bruno Ciancio, ECDC Head of Unit
The ECDC report, published on October 28, 2026, and retrieved on October 29, 2026, from MedicalXpress, states that universal vaccination of pregnant mothers could also reduce RSV hospitalizations among infants by 52% during the first two months of life. Both strategies are part of a broader assessment of interventions to mitigate RSV transmission as autumn and winter respiratory seasons approach.
Maternal Vaccination as an Alternative
The ECDC also estimated that universal vaccination of pregnant mothers could cut RSV hospitalizations among infants by 52% during the same period. Both strategies—newborn immunization and maternal vaccination—are framed as critical measures to ease pressure on healthcare systems as RSV, influenza, and other respiratory viruses surge in autumn and winter.
Experts emphasize that RSV poses a significant risk to infants, with the cold season exacerbating transmission. The ECDC’s analysis underscores the importance of proactive measures to safeguard vulnerable populations and prevent healthcare systems from becoming overwhelmed.
The report, credited to the European Centre for Disease Prevention and Control (ECDC), was authored by Gaby Clark MA in English, a copy editor since 2021 with experience in higher education and health content. Andrew Zinin Master’s in physics with research experience. Long-time science news enthusiast. Plays key role in Science X’s editorial success. The document is subject to copyright, with reproduction prohibited without written permission. The content is provided for information purposes only.
RSV, influenza, and other respiratory infections can place additional strain on healthcare systems across Europe during colder months. The ECDC’s models highlight the potential of immunization strategies to reduce hospitalizations, aligning with broader public health efforts to protect infants. Readers are advised to consult qualified professionals for personalized guidance, as the evidence does not provide medical advice.
>